[Title of Each Class Name of Each Exchange on Which Registered Common Shares, par value NT$10.00 each* None (Title of Class) None (Title of Class) Indicate the number of outstanding shares of each of the issuers classes of capital or common stock as of the close of the period covered by the annual r]
[FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): April 19, 2018 (April 14, 2018) AMERICAN LORAIN CORPORATION Nevada 001-34449 87-0430320 (State or other jurisdiction (I.R.S. Employer Identification of incorporation or organization) Number) Beihuan Road Junan County Shandong,]
[Taiwan Semiconductor Manufacturing Company Ltd. By Lora Ho Senior Vice President & Chief Financial Officer TSMC Reports First Quarter EPS of NT$3.46 Hsinchu, Taiwan, R.O.C., April 19, 2018 Year-over-year, first quarter revenue increased 6.1% while net income and diluted EPS both increased 2.5%. Co]
[Number 99.1 Annual Report 2017. SINOPEC SHANGHAI PETROCHEMICAL COMPANY LIMITED Wu Haijun President Important Message 2 Definitions 4 Company Profile 5 Financial Highlights 6 Principal Products 11 Change in Share Capital of Ordinary Shares and Shareholders 13 Directors, Supervisors, Senior Management]
[Taiwan Semiconductor Manufacturing Company Ltd. By Lora Ho Senior Vice President & Chief Financial Officer TSMC Reports First Quarter EPS of NT$3.46 Hsinchu, Taiwan, R.O.C., April 19, 2018 Year-over-year, first quarter revenue increased 6.1% while net income and diluted EPS both increased 2.5%. Co]
[Number 99.1 Annual Report 2017. SINOPEC SHANGHAI PETROCHEMICAL COMPANY LIMITED Wu Haijun President Important Message 2 Definitions 4 Company Profile 5 Financial Highlights 6 Principal Products 11 Change in Share Capital of Ordinary Shares and Shareholders 13 Directors, Supervisors, Senior Management]
[Large accelerated filer [ ] Accelerated filer [ ] Non-accelerated filer [x] Emerging growth company [ ] † The term “new or revised financial accounting standard” refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012. U.S.]
[Sinovac Sets the Record Straight Regarding False Statements by Shandong Sinobioway Biomedicine Co., Ltd. - Expresses Concern over Aggressive and Damaging Actions Taken by a Minority Shareholder of Sinovac's Beijing Subsidiary – - Reaffirms Commitment to Take All Appropriate Actions to Protect Compan]
[Sinovac Announces Preliminary Results of Phase III Trial on sIPV BEIJING, April 19, 2018 -- Sinovac Biotech Ltd. (NASDAQ: SVA) ("Sinovac " or the "Company"), a leading provider of biopharmaceutical products in China, today announced preliminary results of a phase III clinical study on Sabin inactiva]
